| Product Code: ETC13329502 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Lung Cancer Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Lung Cancer Diagnostics Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Lung Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Lung Cancer Diagnostics Market - Industry Life Cycle |
3.4 Europe Lung Cancer Diagnostics Market - Porter's Five Forces |
3.5 Europe Lung Cancer Diagnostics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Lung Cancer Diagnostics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Europe Lung Cancer Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Europe Lung Cancer Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Europe Lung Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Lung Cancer Diagnostics Market Trends |
6 Europe Lung Cancer Diagnostics Market, 2021 - 2031 |
6.1 Europe Lung Cancer Diagnostics Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Lung Cancer Diagnostics Market, Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031 |
6.1.3 Europe Lung Cancer Diagnostics Market, Revenues & Volume, By Small Cell Lung Cancer, 2021 - 2031 |
6.2 Europe Lung Cancer Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Lung Cancer Diagnostics Market, Revenues & Volume, By Imaging, 2021 - 2031 |
6.2.3 Europe Lung Cancer Diagnostics Market, Revenues & Volume, By Biopsy, 2021 - 2031 |
6.2.4 Europe Lung Cancer Diagnostics Market, Revenues & Volume, By Molecular Testing, 2021 - 2031 |
6.3 Europe Lung Cancer Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Lung Cancer Diagnostics Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Europe Lung Cancer Diagnostics Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.3.4 Europe Lung Cancer Diagnostics Market, Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031 |
7 Europe Lung Cancer Diagnostics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Lung Cancer Diagnostics Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Lung Cancer Diagnostics Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Germany Lung Cancer Diagnostics Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 France Lung Cancer Diagnostics Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.4 Poland Lung Cancer Diagnostics Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.5 Spain Lung Cancer Diagnostics Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.6 Rest of Europe Lung Cancer Diagnostics Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 Europe Lung Cancer Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
7.3.1 United Kingdom (UK) Lung Cancer Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.2 Germany Lung Cancer Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.3 France Lung Cancer Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.4 Poland Lung Cancer Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.5 Spain Lung Cancer Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.6 Rest of Europe Lung Cancer Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4 Europe Lung Cancer Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United Kingdom (UK) Lung Cancer Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Germany Lung Cancer Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 France Lung Cancer Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.4 Poland Lung Cancer Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.5 Spain Lung Cancer Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.6 Rest of Europe Lung Cancer Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Europe Lung Cancer Diagnostics Market Key Performance Indicators |
9 Europe Lung Cancer Diagnostics Market - Export/Import By Countries Assessment |
10 Europe Lung Cancer Diagnostics Market - Opportunity Assessment |
10.1 Europe Lung Cancer Diagnostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Lung Cancer Diagnostics Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 Europe Lung Cancer Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.4 Europe Lung Cancer Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
11 Europe Lung Cancer Diagnostics Market - Competitive Landscape |
11.1 Europe Lung Cancer Diagnostics Market Revenue Share, By Companies, 2022 |
11.2 Europe Lung Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here